Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Stanojevic

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Cytotherapy|April 9, 2021
Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapiesMaja Stanojevic, Amy B Hont, Ashley Geiger, et al.
Blood Advances|September 8, 2021
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphomaHema Dave, Madeline Terpilowski, Mimi Mai, et al.
AIDS (London, England)|September 21, 2022
HIV-1 subtype B spread through cross-border clusters in the Balkans: a molecular analysis in view of incidence trendsLuka Jovanovic, Marina Siljic, Valentina Cirkovic, et al.
Blood|May 16, 2009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesPatrick J Hanley, Conrad Russell Young Cruz, Barbara Savoldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2019
Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I StudyAmy B Hont, C Russell Cruz, Robert Ulrey, et al.
Blood Advances|March 4, 2022
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMTHannah Kinoshita, Kenneth R Cooke, Melanie Grant, et al.
Plos One|July 9, 2014
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemicAndrea-Clemencia Pineda-Peña, Yoeri Schrooten, Lore Vinken, et al.
Frontiers in Public Health|January 2, 2026
Transdisciplinary training to address challenges in genomic epidemiology of infectious diseasesSamuel L Hong, Marie Stockman, Jorge Ricardo Nova Blanco, et al.
The Journal of Infectious Diseases|October 20, 2009
Transmission of drug-resistant HIV-1 is stabilizing in EuropeJurgen Vercauteren, Annemarie M J Wensing, David A M C van de Vijver, et al.
The Journal of Infectious Diseases|December 17, 2014
Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast AsiaKonstantinos Angelis, Jan Albert, Ioannis Mamais, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Cytotherapy|April 9, 2021
Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapiesMaja Stanojevic, Amy B Hont, Ashley Geiger, et al.
Blood Advances|September 8, 2021
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphomaHema Dave, Madeline Terpilowski, Mimi Mai, et al.
AIDS (London, England)|September 21, 2022
HIV-1 subtype B spread through cross-border clusters in the Balkans: a molecular analysis in view of incidence trendsLuka Jovanovic, Marina Siljic, Valentina Cirkovic, et al.
Blood|May 16, 2009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesPatrick J Hanley, Conrad Russell Young Cruz, Barbara Savoldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2019
Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I StudyAmy B Hont, C Russell Cruz, Robert Ulrey, et al.
Blood Advances|March 4, 2022
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMTHannah Kinoshita, Kenneth R Cooke, Melanie Grant, et al.
Plos One|July 9, 2014
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemicAndrea-Clemencia Pineda-Peña, Yoeri Schrooten, Lore Vinken, et al.
Frontiers in Public Health|January 2, 2026
Transdisciplinary training to address challenges in genomic epidemiology of infectious diseasesSamuel L Hong, Marie Stockman, Jorge Ricardo Nova Blanco, et al.
The Journal of Infectious Diseases|October 20, 2009
Transmission of drug-resistant HIV-1 is stabilizing in EuropeJurgen Vercauteren, Annemarie M J Wensing, David A M C van de Vijver, et al.
The Journal of Infectious Diseases|December 17, 2014
Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast AsiaKonstantinos Angelis, Jan Albert, Ioannis Mamais, et al.
Pageof 6